MacroGenics financials
$3.77−7.14%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32.8M | $20.8M | $41.2M | $72.8M | $6.9M | $13.2M | $19.4M | $110.7M | $10.8M | $9.1M | $10.7M | $10.4M |
| Gross profit | $32.8M | $11.2M | $31.1M | $61.3M | $6.9M | $7.8M | $13.9M | $108.8M | $8.0M | $7.0M | $10.6M | $7.0M |
| Gross margin | 100.0% | 54.1% | 75.5% | 84.1% | 100.0% | 59.1% | 71.6% | 98.3% | 73.9% | 76.8% | 98.5% | 67.7% |
| Operating income | -$13.9M | -$33.4M | -$12.1M | $18.6M | -$43.2M | -$42.6M | -$52.8M | $54.2M | -$58.2M | -$53.8M | -$49.4M | -$35.5M |
| Net income | $19.5M | -$36.8M | -$14.2M | $16.8M | -$36.3M | -$41.0M | -$15.4M | $56.3M | -$55.7M | -$52.2M | -$46.1M | $17.6M |
| Net margin | 59.4% | −177.3% | −34.3% | 23.1% | −527.7% | −311.1% | −79.7% | 50.9% | −515.4% | −573.3% | −429.8% | 168.8% |
| Diluted EPS | $0.31 | $-0.58 | $-0.22 | $0.27 | $-0.57 | $-0.65 | $-0.25 | $0.90 | $-0.89 | $-0.84 | $-0.75 | $0.28 |
| EBITDA | -$13.1M | -$31.8M | -$10.4M | $20.4M | -$41.3M | -$40.9M | -$50.8M | $56.0M | -$56.4M | -$51.9M | -$49.4M | -$33.6M |
| Operating cash flow | -$40.7M | -$35.8M | $43.0M | -$30.2M | -$47.0M | -$46.9M | -$38.4M | $60.2M | -$44.5M | -$45.6M | -$28.0M | -$35.2M |
| Free cash flow | -$41.6M | -$36.2M | $42.8M | -$30.6M | -$47.7M | -$47.4M | -$39.0M | $59.6M | -$45.5M | -$47.1M | -$28.7M | -$35.7M |
| Diluted shares | 63.6M | 63.4M | 63.2M | 63.3M | 63.1M | 63.0M | 62.7M | 62.9M | 62.7M | 62.3M | 61.4M | 62.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $113.9M | $66.5M | $57.2M | $80.1M | $130.7M | $145.6M |
| Short-term investments | $59.4M | $87.7M | $132.7M | $66.3M | $0.00 | $8.6M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $345.4M | $217.9M | $256.8M | $270.8M | $245.4M | $224.6M |
| Total liabilities | $302.5M | $196.7M | $201.3M | $203.8M | $198.8M | $145.4M |
| Shareholders' equity | $42.9M | $21.2M | $55.6M | $67.0M | $46.6M | $79.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology